Skip links

Trends Transforming The Pharmaceutical Industry Outlook in 2023

There has been tremendous growth in the pharmaceutical industry in recent years, and the outlook continues to be positive for 2023. The industry is expected to exceed $1 trillion by the following year. This is partly due to thousands of compounds currently in the latter stages of clinical development, coupled with hundreds of new products with approvals anticipated in 2023 and beyond. This level of pharmaceutical products is not customary and has not occurred for about a decade. Let’s closely examine ten trends transforming the pharmaceutical industry in 2023.

Trends In Pharmaceutical Industry Shaping The Industry In 2023

1. Use of Artificial Intelligence

Artificial intelligence (AI) is a term that is becoming increasingly popular across all industries. It’s essentially the use of computer systems to perform tasks that would otherwise require human intelligence. This includes tasks like decision-making, speech recognition, and visual perception. It also enables the translation of information between different languages. The use of AI in the pharmaceutical industry has different roles expected to expand, such as accelerating drug discovery and development. Some of the areas that will benefit from AI include clinical trials, fraud detection, and the overall improvement of medications.

2. Greater Acceptance of Medical Marijuana

Without a doubt, there are some doctors that were not eager to jump on the medical marijuana bandwagon, even after it became more widely accepted. This is starting to change, a trend that will continue in 2023. Simply put, the perception of cannabidiol (CBD) when used as a medication is changing. Many healthcare professionals who found it difficult to accept in the past cannot deny the benefits that have become evident when using medical marijuana for pain reduction, mood regulation, digestive functions, and vascular health, among other conditions. Subsequently, pharmaceutical companies recognize the tremendous opportunities that exist.

3. Precision Medicine

Personalized medicine is when medication is produced based on a specific patient diagnosis. The purpose is to ensure the drug is tailored for optimal effectiveness and patient outcomes. The use of precision medication has demonstrated a higher level of effectiveness than other options. The problem for manufacturers is that a smaller quantity of medication is produced, which means there is more than one treatment variation. Notably, the production of precision medicine requires facilities that are specialized and smaller than most factories. Although it has posed problems for manufacturers, this trend is expected to continue as the methods used are refined. The number of investors that have embraced precision medicine has been higher than anticipated.

4. Integration of Blockchain Technology

As blockchain technology has expanded in the financial arena, others have started to identify ways to use this innovation, including companies in the pharmaceutical industry. The primary purpose of blockchain technology is to simplify the way transactions occur while also optimizing security and transparency without requiring a third party. When used by pharmaceutical companies, blockchain technology can help with boosting efficiency by streamlining processes. This applies to transactions that involve healthcare clinics, hospitals, regulators, and other stakeholders. It can also maximize the outcomes of research and development.

5. Digital Processes

The implementation of digital processes isn’t new. However, it is something that will gain momentum in the pharmaceutical industry. There are manual processes that currently exist simply because they have become the norm over the years. For instance, there are many paper processes that have been replaced by digital processes, which have enhanced operational efficiency and facilitated adherence to standard operating procedures with greater ease. This is a trend that will continue. It will also help to drive regulatory compliance. Many pharmaceutical companies appreciate the implementation of digital processes because the benefits far outweigh the costs. It also improves transparency and has the potential to mitigate the loss of data.

6. Smaller Production

As aforementioned, precision medicine requires using smaller manufacturing facilities, unlike what’s needed for the mass production of pharmaceuticals. As a result, there will be an increasing number of small production facilities. These smaller facilities are also due to a desire to produce a smaller number of higher-quality medications instead of producing a large number of lower-quality drugs. When fewer medications are produced, they will serve fewer patients. Notably, some of the challenges associated with this model include the need to ensure maximum profits through fast production to accommodate demands.

7. Use of Cloud Technology

Anyone with a computer at home or work is probably familiar with cloud technology. It has been embraced in the pharmaceutical industry, a trend that will continue. Cloud technology enables pharmaceutical companies to partner with multiple stakeholders with greater effectiveness. Implementing a strong infrastructure using cloud technology also offers an opportunity to improve data integrity. There has been increased compliance with the good practice quality guidelines and regulations (GxP) due to applications used in the cloud. Just as this technology is expanding across all other industries, it will support the pharmaceutical industry’s growth.

8. Discounts and Rebates

Periodically, the pricing of medications will hit the news circuit, especially when there is outrage about the high price of life-saving drugs. In an ongoing desire to reduce the cost of medications, governmental agencies, such as Health and Human Services, will increase discounts and rebates. While there have been past efforts using market-focused approaches, these efforts are expected to expand. One thing that will continue in 2023 is the examination of drug prices and continued scrutiny to identify impropriety.

9. Digital Training

From an operational perspective, one of the trends that will grow in 2023 is the use of digital training to ensure the proper and efficient use of technologies implemented. This is also to achieve regulatory compliance. As in any other industry, pharmaceutical companies and pharmacy employees must have a keen knowledge of regulations and be able to navigate the different systems implemented in a way that complies with regulations. There’s also the issue of knowledge building to maintain high productivity and overall efficiency. Using digital platforms for training is also cost-effective because you can train personnel on-demand at any time of the day or week.

10. Greater Focus on R&D Value

There is an increased focus on the value of medications. As a result, pharmaceutical companies are more concerned than ever about ensuring research and development hits the intended target. There is an effort to achieve greater effectiveness and efficiency in meeting the needs of patients while also protecting the bottom line. For instance, there is research designed to identify medications that can improve patients’ experience and quality of life in a more meaningful way. This has required pharmaceutical companies to examine their research and development practices to ensure they are refined and focused.

These top trends are changing the pharmaceutical industry in ways that are transformative and likely to have both a short- and long-term impact. The level of innovation that’s taking place in the industry is likely to create tremendous value. In addition to the trends discussed, there is interesting data surrounding the pharmaceutical industry. Check out the statistics below:

Pharmaceutical Industry Stats and Growth Projections in 2023

  1. The pharmaceutical industry is expected to increase to $1.5 trillion by 2023.
  2. Approximately 38% of industry experts expect big data to have the greatest impact on the pharmaceutical industry.
  3. More than 450 medications were withdrawn over the past 25 years due to adverse reactions. This is one of the reasons why precision medicine is expected to be such an integral part of the change in the industry.
  4. There are 66 biologic patents in the United States that will expire from 2023 to 2025. As a result, the FDA anticipates an increasing number of biosimilar applications.
  5. Pharmaceutical companies can speed up to $100 million per year on recalls linked to labeling mistakes.